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Adult obesity has been associated with depression, especially in women. Whether depression leads to obesity or obesity causes
depression is unclear. Chronic inﬂammation is observed in obesity and depression. In 63 obese women without additional
diseases depression level was assessed with the Beck’s questionnaire. After evaluation of depression level study group was divided
into groups according to the mood status (A—without depression, B—mild depression, and C—severe depression), and serum
concentration of TNF-α, sTNFs, leptin, and IL-6 were measured by ELISA. No diﬀerences in age, body mass, BMI, and body
composition were observed in study groups. We did not observe diﬀerences of serum concentrations of TNF-α, sTNFRs, leptin,
and IL-6 between subgroup A and subgroups B and C. It seems that circulating adipokines did not exert inﬂuence on depression
levels in obese women.
Copyright © 2009 Magdalena Olszanecka-Glinianowicz et al. This is an open access article distributed under the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
1.Introduction
The prevalence of both obesity and depression has been
increasing for decades [1, 2]. There has been evidence
for association of both disorders with increased risk of
mortality [3], coronary heart disease [4], hypertension [5],
and diabetes [6]. It seems that there may be a link between
obesity and depression.
Adulthood obesity has been associated with depression,
especially in women [7]. This association seems to be clearer
in subjects with central obesity [8]. Central obesity is a
greater risk factor for metabolic complications and cardio-
vascular disease than peripheral obesity [9]. Independent
increase of risk for coronary heart disease in depressive
mood patients may be explained by a positive association
betweendepressionandvisceraladiposetissue[10].Whether
depression leads to obesity or obesity causes depression is
unclear.
It has been shown that depression and obesity share
neurobiological pathophysiological mechanisms [11].
Disturbances in serotonin release may be connected with
recurrent increase of carbohydrate-rich foods consumption
and inability to physical activity [11]. Other evidences
show a link between depressive syndromes, and distorted
hypothalamic-pituitary-adrenal (HPA) axis function; it
seems that chronic excessive action of cortisol is responsible
for accumulating fat [12]. Stress is also a powerful factor
a c t i v a t i n gH P Aa x i s[ 12]. It seems that brain reward circuity
plays the central role in the activation of stress-induced
food intake. Either highly palatable food or activation of
HPA releases opioids attenuating detrimental eﬀect of stress
response by inhibiting HPA [12]. Chronic stress may lead to
dysregulation of balanced system, increase of calories intake,
andvisceralfataccumulation[12]withsuchc onsequenc esas
hypertension, diabetes, and dyslipidemia [13]. New concept
of depression assumes this disorder as a chronic endogenous
stress [14].
It seems that there can be a theoretical link between early
onset stress and morphological changes of neuroendocrine
axis that can cause both obesity and depression [15].
Moreover,unsuccesfulattemptsatfoodrestrictionsasastress2 Mediators of Inﬂammation
factor may cause increase of the value of consumed palatable
food [12]. Increased concentration of cortisol increases
the reward value of food via increased action of peptide
mediators [12]. Mediators enhancing appetite include neu-
ropeptide Y (NPY), leptin, and insulin [12]. Alterations in
modulation mechanisms may lead to compulsive overeating
and seem to be responsible for ineﬀective treatment of
obesity in long term [12]. Disturbation of adrenal hormones
metabolism seen in depression and disturbances in carbo-
hydrates and lipid metabolism may lead to the development
of metabolic syndrome, a factor promoting atherosclerosis
and development of cardiovascular disease and increase of
mortality [16].
Current study on pathopysiology of depression revealed
thatimmuneactivationobservedinobesitymaybeonecause
of development of depression [17].
The aim of the study was to assess serum concentrations
of TNF-α, TNF soluble receptors, leptin, and interleukin-6
(IL-6 ) in obese subjects with and without depression.
2.MaterialandMethods
The study was carried out on 63 obese women—weight
98.2 ± 16.4kg,aged55.6 ± 7.5 years. Their body mass index
(BMI) was 37.9 ± 5.5kg/m2. A l ls u b j e c t sw e r ed i a g n o s e d
as having simple obesity with no concomitant diseases and
without any pharmacological treatment. The weight of our
obese patients was stable at the enrollment—both patients
with the sudden lost and patients with the sudden increase
of weight were excluded from the observation. Their case
histories of obesity have lasted for at least some years.
The exclusion criteria included evidence of present or
recent (preceding 3 months) infectious disease, fever, and
drug therapy.
The study was approved by the local ethics committee.
All subjects gave their informed consent for the study.
The body weight and height were measured, and body
mass index (BMI) was calculated. Body composition was
assessed by impedance analysis using Bodystat analyzer.
The Beck’s questionnaire was used to assess depression
level. After evaluation of depression level study group was
diﬀerentiated into subgroups: A—subjects without depres-
sion (6.1 ± 3.0 points) n = 24, B—subjects with mild
depression n = 33, and C—subjects with severe depression
n = 5.
The determinations of TNF-α and sTNFRs, leptin, and
IL-6 in the serum were carried out by enzyme-linked
immunosorbent assay. 6–8mL samples of venous blood
were collected from each subject in the morning, after an
overnight fast between 8-9a.m. After clot formation, the
samples were centrifuged (1000g) at a room temperature for
10 minutes. The obtained serum was drawn into a few plastic
vials and stored at −80
◦C until the time of assay.
TNF-α a n ds o l u b l ef o r m so fb o t hT N F - α receptors
(sTNF-R1 and sTNF-R2) were measured using a com-
mercially available highly sensitive ELISA kits (Genzyme
Diagnostics, Cambridge, USA).
Table 1: Patients’ characteristics.
ABC
N 24 33 5
Age (year) 53.7 ±6.05 7 .0 ± 8.25 5 .6 ± 8.5
Body mass (kg) 96.8 ±14.59 8 .8 ±16.2 101.2 ± 27.9
BMI (kg/m2)3 7 .1 ±4.63 8 .3 ± 5.83 8 .8 ± 8.3
Body fat (kg) 48.2 ±11.85 1 .1 ±12.95 1 .6 ±22.2
Body fat (%) 49.3 ±6.55 1 .2 ± 7.04 9 .5 ± 7.8
Fat-free mass (kg) 48.6 ±7.24 7 .4 ± 7.64 9 .5 ± 6.3
Fat-free mass (%) 50.8 ±6.44 8 .8 ± 7.45 0 .5 ± 7.6
Waist
circumference
(cm) 102.0 ±22.2 106.8 ± 11.4 110.0 ± 18.3
The minimum detectable concentration of TNF-α is
typically less than 0.18pg/mL. Mean intraassay coeﬃcient
of variance was 14.4%, and mean interassay coeﬃcient of
variance was 18.7%.
The minimum detectable concentration of sTNF-R1 is
typically less than 3.0pg/mL. Mean intraassay coeﬃcient
of variance was 2.9%, and mean interassay coeﬃcient of
variance was 3.7%.
The minimum detectable concentration of sTNF-R2 is
typically less than 1.0pg/mL. Mean intraassay coeﬃcient
of variance was 2.5%, and mean interassay coeﬃcient of
variance was 3.5%.
Leptin was measured using a commercially available
highly sensitive ELISA kits (BioVendor Laboratory Medicine
Inc., Czech Republic).
The minimum detectable concentration of leptin is
typically less than 0.17ng/mL. Mean intraassay coeﬃcient
of variance was 5.4%, and mean interassay coeﬃcient of
variance was 7.8%.
IL-6 was measured using a commercially available highly
sensitive ELISA kits (Diagnostic Products Corporation,
USA).
The minimum detectable concentration of IL-6 is typ-
ically less than 1.0pg/mL. Mean intraassay coeﬃcient of
variance was 10.0%, and mean interassay coeﬃcient of
variance was 10.0%.
Allt e xtandtableval uesar ee xp r essedasmeans±SD.The
U-Manna-Withney’s test was used to compare study groups.
The relationships between study parameters were examined
by Spearman’s correlation analysis. A value P<. 05 was
considered statistically signiﬁcant.
3. Results
The characteristics of study subgroups are presented in
Table 1.
There were no diﬀerences of age, body mass, BMI, and
body composition between study subgroups (Table 1).
We did not observe diﬀerences of serum concentrations
of TNF-α, sTNFRs, leptin, and IL-6 between subgroup A and
subgroups B and C (Table 2).Mediators of Inﬂammation 3
Table 2: Serum concentrations of TNF-α, soluble TNF receptors, leptin, and IL -6.
ABC
TNF-α (pg/mL) 5.9 ±2.06 .4 ±2.04 .9 ±2.7
sTNFR1 (pg/mL) 1369.6 ±528.3 1535.5 ±556.38 1554.2 ±674.8
sTNFR2 (pg/mL) 2179.6 ±704.2 2259.7 ±726.2 2323.3 ±582.3
Leptin (ng/mL) 34.0 ±12.13 2 .8 ±18.13 2 .4 ±12.3
IL-6 (pg/mL) 10.1 ±3.41 0 .3 ±3.38 .7 ±3.0
We found positive correlations between body mass and
serum concentration of TNF and sTNFR1 (r = 0.4802,P =
.032 and r = 0.4518,P = .046, resp.) and between BMI
and sTNFR 1 concentration and (r = 0.4451,P = .049) in
subgroup A.
Positive correlations between body mass and serum con-
centrations of sTNFR 2 and leptin were found in subgroup
B( r = 0.3354,P = .03 and r = 0.3046,P = .05, resp.)
and between BMI and serum concentrations of sTNFR 2 and
leptin (r = 0.3446,P = .025 and r = 0.4004,P = .009, resp.).
When the depressive subjects were divided into pre- and
postmenopausal, no diﬀerences in weight, body composi-
tion,andwaistcircumferencewereobserved.Therewerealso
no diﬀerences between study cytokines. In the nondepressive
subjects there were also no diﬀerences in study parameters
between pre- and postmenopausal women.
4. Discussion
In some epidemiological studies the relationship between
obesity and depression was established [18]. It suggests that
depression may be a trigger for development of visceral
obesity.Ithasbeenpostulatedthatinsubjectswithdepressive
syndrome accumulation of visceral fat occurs, which pro-
motes inﬂammatory response [19]. In the increased release
of cytokines in depressive patients at least two mechanisms
are involved: expanded release of cytokines from adipose
tissue and upregulation of interleukin release by leptin [19].
In our recent study [20–22] we observed increased
serum concentrations of TNF-α and IL-6 and other authors
[23] revealed increased serum concentration of leptin in
obese subjects. Increased concentrations of cytokines were
explained as a result of increased visceral adiposity in depres-
sive patients [19]. Cytokines are responsible for increased
risk for coronary heart disease and diabetes [24, 25]. As it
was described above these medical conditions may be factors
of depression enhancing.
In the present study we did not observe diﬀerences of
serum concentrations of TNF-α,I L - 6 ,a n dl e p t i nb e t w e e n
depressive and nondepressive patients with obesity. These
results are contradictory to results obtained by Miller’s
et al. [26], who observed elevated concentrations of IL-
6 in depressive patients. However, patients with depressive
syndrome studied by these authors had greater body mass
than controls, which could, in part, be responsible for
increased concentration of cytokine. Recent study revealed
that about 30% of IL-6 is produced in adipose tissue
[27]. In other papers published by Miller’s et al. [19]
no diﬀerences in cytokines such as IL-6 and leptin were
detected in young obese persons with and without depressive
syndrome.
Yang et al. [28] found higher concentrations of serum
levelofIL-6,TNF-α,andlowerlevelofleptininsubjectswith
depression in comparison to controls without depressive
disorder; moreover, higher levels of leptin were observed in
both healthy and depressive women than in men. In these
studies BMI was not considerd as a factor that may inﬂuence
cytokines levels.
Results obtained by Lesp´ erance’s et al. study [29]a r e
in accordance with ours, because they did not also reveal
diﬀerences in circulating level of interleukin-6 between sub-
jects with and without depression and association between
concentration of IL-6 and the level of depression.
On the other hand, Levine et al. [30] revealed increased
level of interleukin-1 beta, interleukin-6 were detected
in cerebrospinal ﬂuid in acute diagnosed depression, but
there were no diﬀerences in TNF-α concentrations between
depressive patients and healthy controls. Unfortunately, on
the basis of these interesting results, it is diﬃcult to explain
if increased concentrations of these cytokines are primary or
secondary to depression.
Further studies are necessary to clarify the association
betweenimmuneactivationanddepression.However,taking
into account that obesity often accompanies depression and
the obesity itself is a chronic inﬂammation process, nutrition
status of study subjects is very important while analyzing
resultsfromstudiesondepressivepatients.Thishypothesisis
supported by the observed, in our study, signiﬁcant positive
correlations between BMI and serum concentrations of
sTNFR 2 and BMI and leptin in depressive, obese subject,
whichsuggestthatthelevelofobesityismoreassociatedwith
immune activation than depression.
5. Conclusions
It seems that circulating adipokines did not exert inﬂuence
on depression levels in obese women.
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